Literature DB >> 11096022

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.

P Muñoz1, M Marín, P Tornero, P Martín Rabadán, M Rodríguez-Creixéms, E Bouza.   

Abstract

A disseminated Scedosporium apiospermum infection was diagnosed in a woman with severe asthma and treated with corticosteroids. This fungi is resistant to fluconazole and amphotericin B. The infection was refractory to itraconazole, but responded successfully to voriconazole. A review of the literature is provided.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11096022     DOI： 10.1086/317496

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  20 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

2.  In vitro activities of four novel triazoles against Scedosporium spp.

Authors:  A J Carrillo; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.

Authors:  Javier Capilla; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 4.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 5.  Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

Authors:  Helen W Boucher; Andreas H Groll; Christine C Chiou; Thomas J Walsh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.

Authors:  Javier Capilla; Carolina Serena; F Javier Pastor; Montserrat Ortoneda; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

7.  Tracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodies.

Authors:  Christopher R Thornton
Journal:  Clin Vaccine Immunol       Date:  2009-03-25

8.  Voriconazole in the treatment of invasive mold infections in transplant recipients.

Authors:  J Fortún; P Martín-Dávila; M A Sánchez; V Pintado; M E Alvarez; A Sánchez-Sousa; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

9.  Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.

Authors:  Lynn Purkins; Nolan Wood; Katie Greenhalgh; Michael J Allen; Stuart D Oliver
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

10.  Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays.

Authors:  Gloria M González; Rolando Tijerina; Laura K Najvar; Rosie Bocanegra; Michael G Rinaldi; David Loebenberg; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.